New drug delivery for corneal neovascularization using polyion complex micelles

Cornea

Volumn 24, Issue 8 SUPPL., 2005, Pages

  Usui, Tomohiko ^a   Sugisaki, Kenji ^a   Amano, Shiro ^a   Jang, Woo Dong ^b   Nishiyama, Nobuhiro ^c   Kataoka, Kazunori ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Cornea; Drug delivery; Nanomicelle; Photodynamic therapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN A; DENDRIMER; DRUG CARRIER; MACROGOL; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOTOSENSITIZING AGENT; POLYION COMPLEX; PORPHYRIN; TACROLIMUS; THALIDOMIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; CONFERENCE PAPER; CONTROLLED DRUG RELEASE; CORNEA NEOVASCULARIZATION; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENCAPSULATION; HUMAN; MICELLE; PHOTODYNAMIC THERAPY; PHOTOOXIDATION; PRIORITY JOURNAL;

EID: 28044442970     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000178738.29459.59     Document Type: Conference Paper

References (22)

1. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43:245-269.
2. Amano S, Rohan R, Kuroki M, et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22.
3. Yoshida S, Yoshida A, Matsui H, et al. Involvement of macrophage chemotactic protein-1 and interleukin-1 beta during inflammatory but not basic fibroblast growth factor-dependent neovascularization in the mouse cornea. Lab Invest. 2003;83:927-938.
4. 164 (165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest Ophthalmol Vis Sci. 2004;45:368-374.
5. Crusiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113:1040-1050.
6. Binetruy-Tournaire R, Demangel C, Malavaud B, et al. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J. 2000;19:1523-1533.
7. Mahoney JM, Waterbury LD. Drug effects on the neovascularization response to silver nitrate cauterization of rat cornea. Curr Eye Res. 1985; 4:531-535.
8. Nikolic L, Friend J, Taylor S, et al. Inhibition of vascularization in rabbit corneas by heparin: cortisone pellets. Invest Ophthalmol Vis Sci. 1986;27: 449-456.
9. BenEzra D, Griffin BW, Maftzir G, et al. Topical formulation of novel angiostatic steroids inhibits rabbit corneal neovascularization. Invest Ophthalmol Vis Sci. 1997;38:1954-1962.
10. Haynes WL, Proja AD, Klintworth GK. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci. 1989;30:1588-1593.
11. Yamada M, Kawai M, Kawai Y, et al. The effect of selective cyclooxygenase-2 inhibitor on corneal neovascularization in the rat. Curr Eye Res. 1999;19:300-304.
12. Gohto Y, Obana A, Kanai M, et al. Treatment parameter for selective occlusion of experimental corneal neovascularization by photodynamic therapy using a water soluble photosensitizer, ATX-S10 (Na). Exp Eye Res. 2001;72:13-22.
13. Holzer MO, Solomon KD, Vroman DT, et al. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:2954-2958.
14. Zhang GD, Harada A, Nishiyama N, et al. Polyion complex micelles entrapping cationic dendrimer porphyrin for photodynamic therapy of cancer. J Control Release. 2003;93:141-150.
15. Jang WD, Nishiyama N, Zhang GD, et al. Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy. Angrew Chem Int Ed Engl. 2005;44:419-423.
16. Kataoka K, Harada A, Nagasaki Y Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47:113-131.
17. Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev. 2002;54:203-222.
18. Nakanishi T, Fukushima S, Okamoto K, et al. Development of the polymer micelle carrier system for doxorubicin. J Control Release. 2001; 74:295-302.
19. Nishiyama N, Kato Y, Sugiyama Y, et al. Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system. Pharm Res. 2001;18:1035-1041.
20. Nisiyama N, Okazaki S, Cabral H, et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 2003; 63:8977-8983.
21. Harada A, Kataoka K. Pronounced activity of enzymes through the incorporation into the core of polyion complex micelles made from charged block copolymers. J Control Release. 2001;72:85-91.
22. Harada-Shiba M, Yamauchi K, Harada A, et al. Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer. Gene Ther. 2002;9:407-414.